{"id":"https://genegraph.clinicalgenome.org/r/264745c2-d298-433e-b07c-461354e6d1d7v1.1","type":"EvidenceStrengthAssertion","dc:description":"The IGF2 gene is located on chromosome 11p15.5 and encodes insulin-like growth factor 2, a protein hormone that regulates cell proliferation, growth, migration, differentiation, and survival. The protein binds and activates Insulin Receptor Tyrosine - A (IR-A) and IGF-1R. The receptor  structural change leads to activation of the intracellular tyrosine kinase domain and autophosphorylation with an outcome of growth promoting effect (Blyth et al., 2020). The gene has 5 promoters that are differentially activated during pre and postnatal life. There are 9 exons in total however, only the last 3 exons are coding exons (Röttgering and Szuhai 2019). Additionally, IGF2 is a paternally expressed, maternally imprinted gene with an imprinting control region (ICR1) located between the H19 and IGF2 genes. \n\nIGF2 was first reported in relation to autosomal dominant Silver-Russell syndrome 3 in 2015 (Begemann et al., PMID: 26154720). Silver-Russell Syndrome 3 is caused by heterozygosity pathogenic variants in the paternal copy of the IGF2 gene. Features seen in Silver-Russell syndrome 3 patients include intrauterine growth retardation with relative macrocephaly, feeding difficulties, growth restriction, triangular face, prominent forehead, low-set ears, limb defects, genitourinary and cardiovascular anomalies, hearing impairment, and developmental delay. \n\nThirteen variants (5 missense, 3 frameshifts, 3 splice site, 2 nonsense) reported in thirteen probands in eight publications (PMIDs: 26154720, 28848601,28489339, 30152198, 28796236, 30400067, 31803239, 31544945) are include in this curation. The most common mechanism of disease is loss of methylation at the chromosome 11p15. A total of 10.6 pts for genetic evidence was reached, considering case-level data. This gene-disease relationship is supported by expression, biochemical, and two mouse models (PMIDs: 33567274, 2621730, 32459985, 2330056).\n\nIn summary, there is definitive evidence supporting the relationship between IGF2 and autosomal dominant Silver-Russell Syndrome 3. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. The classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date 10/04/2023 (SOP Version 9).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/264745c2-d298-433e-b07c-461354e6d1d7","GCISnapshot":"https://genegraph.clinicalgenome.org/r/39e89185-94a4-4f94-ae80-63df06bece69","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/39e89185-94a4-4f94-ae80-63df06bece69_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2023-10-04T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/39e89185-94a4-4f94-ae80-63df06bece69_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-01-22T21:08:06.493Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39e89185-94a4-4f94-ae80-63df06bece69_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/acdbc92a-84f8-45f1-b998-711d964aab9c","type":"EvidenceLine","dc:description":"Downgraded because WGS(trio) was not performed to confirm de novo.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/acdbc92a-84f8-45f1-b998-711d964aab9c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28489339","allele":{"id":"https://genegraph.clinicalgenome.org/r/6937b984-52db-4622-80ce-d415f990949f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.110_117delinsAGGTAA (p.Leu37GlnfsTer31)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139661771"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3ee0b28b-c69c-481a-a313-9f625cf314e6","type":"EvidenceLine","dc:description":"Downgraded because WGS was not performed.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ee0b28b-c69c-481a-a313-9f625cf314e6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31544945","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e175318-0ac2-4d67-8a30-87af0f617107","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.97T>A (p.Cys33Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379113907"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bedf477a-72cb-4f63-b337-81a7e9b4701b","type":"EvidenceLine","dc:description":"Downgraded because WGS(trio) was not performed to confirm de novo.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bedf477a-72cb-4f63-b337-81a7e9b4701b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28848601","allele":{"id":"https://genegraph.clinicalgenome.org/r/a1b494dc-2aaf-4368-ae66-0bedb9d96d80","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.101G>A (p.Gly34Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379113898"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7fa29e9f-cc2f-47ca-99bd-a3d1f81b9370","type":"EvidenceLine","dc:description":"Downgraded because WGS(trio) was not performed for de novo confirmation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fa29e9f-cc2f-47ca-99bd-a3d1f81b9370_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28796236","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8018cdb-7c3a-41bb-8b93-7547f804d9c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.78C>G (p.Tyr26Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16616844"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/de92578c-9f1a-43f6-ac8e-021fbf7bfc1d","type":"EvidenceLine","dc:description":"Downgraded because WGS was not performed.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de92578c-9f1a-43f6-ac8e-021fbf7bfc1d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26154720","allele":{"id":"https://genegraph.clinicalgenome.org/r/5fde5d21-bbda-4667-927d-4f21ee9c979d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.23C>A (p.Ser8Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358705"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/73153320-6c6a-48c2-b732-3a439427d577","type":"EvidenceLine","dc:description":"Downgraded because WGS(trio) was not performed to confirm de novo.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73153320-6c6a-48c2-b732-3a439427d577_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31803239","allele":{"id":"https://genegraph.clinicalgenome.org/r/6dd8f32a-58b4-4d99-86ac-0751b974ae98","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.157+5G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580652580"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/93f718a4-c481-4b29-9811-3fab8e7543fc","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93f718a4-c481-4b29-9811-3fab8e7543fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30400067","allele":{"id":"https://genegraph.clinicalgenome.org/r/2daa6752-df05-4bfe-a1ca-12956cb11624","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.195del (p.Ile66SerfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139661769"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/93f718a4-c481-4b29-9811-3fab8e7543fc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Investigated the capacity of the p.I66S variant to activate IGF1R. IGF2-WT was seen to activate IGF1R  after  IGF1R/IGF2 co-transfection, while the p.I66S mutant showed an impaired activation capacity, demonstrating p.I66S IGF2 variant is nonfunctional.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/325b0a65-4383-43c4-8ab5-03968c92d3e7","type":"EvidenceLine","dc:description":"Downgrade because WGS was not performed.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/325b0a65-4383-43c4-8ab5-03968c92d3e7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31544945","allele":{"id":"https://genegraph.clinicalgenome.org/r/344ef2c0-83d2-4b5f-af92-b7479eb72da5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.211T>C (p.Cys71Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379113626"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/47301974-0fa1-43b0-ba8a-2cc9951c008e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47301974-0fa1-43b0-ba8a-2cc9951c008e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30152198","allele":{"id":"https://genegraph.clinicalgenome.org/r/6ac86014-837d-4ec9-a032-1806241a1af9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.157+3A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139661770"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f263debb-580d-4f72-aba6-dd914c70555b","type":"EvidenceLine","dc:description":"Downgraded because WGS(trio) was not performed to confirm de novo.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f263debb-580d-4f72-aba6-dd914c70555b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28796236","allele":{"id":"https://genegraph.clinicalgenome.org/r/cdad3042-7b8b-4206-8173-a518b7c860c6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.158_159dup (p.Arg54AlafsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580652579"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b0cb1bc8-40ee-4146-83e8-b6a8efb19a16","type":"EvidenceLine","dc:description":"Downgraded because WGS was not performed. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0cb1bc8-40ee-4146-83e8-b6a8efb19a16_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31544945","allele":{"id":"https://genegraph.clinicalgenome.org/r/7bfefd7d-6975-4ef9-8a42-2136acec9571","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.-6-1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379114120"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e82be1bf-652b-45c7-ac70-c4ad5cc4330a","type":"EvidenceLine","dc:description":"Downgraded because WGS was not performed. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e82be1bf-652b-45c7-ac70-c4ad5cc4330a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31544945","allele":{"id":"https://genegraph.clinicalgenome.org/r/8fb172ef-c888-41d3-8a5f-539590243fd8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.134G>C (p.Cys45Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379113825"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3e3b33e6-64ee-4f02-ba06-b209786f988f","type":"EvidenceLine","dc:description":"Downgraded because WGS was not performed.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e3b33e6-64ee-4f02-ba06-b209786f988f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31544945","allele":{"id":"https://genegraph.clinicalgenome.org/r/226aa58d-af31-47f2-95cd-259ffec2b362","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000612.6(IGF2):c.209G>A (p.Cys70Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379113631"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/39e89185-94a4-4f94-ae80-63df06bece69_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/477f7cda-d486-4f1d-9197-55abc4b8f5db_proband_segregation","type":"FamilyCosegregation","dc:description":"Exome Sequencing","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26154720","rdfs:label":"Begemann_Family ","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/477f7cda-d486-4f1d-9197-55abc4b8f5db","type":"Family","rdfs:label":"Begemann_Family ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/2c12f6f6-b54a-4e9e-8a83-5ca9ff3e5a1c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26154720","rdfs:label":"Begemann_Index","ageType":"AgeAtReport","ageUnit":"Years","ageValue":26,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5fde5d21-bbda-4667-927d-4f21ee9c979d"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/de92578c-9f1a-43f6-ac8e-021fbf7bfc1d_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Hypotrophy, macrocephaly, right ulnar ray defect (digits 3 to 5 were missing), contracture of the right elbow with a pterygium, severe feeding problems, delayed psychomotor milestones,  low intelligence, severe hypotonia, high-pitched voice, bone age lagged\n","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/2c12f6f6-b54a-4e9e-8a83-5ca9ff3e5a1c"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10.6},{"id":"https://genegraph.clinicalgenome.org/r/39e89185-94a4-4f94-ae80-63df06bece69_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39e89185-94a4-4f94-ae80-63df06bece69_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5fb03c51-65e7-4ad5-93ce-cb8c6fe29c6f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4633a66b-3870-4f01-9076-3e0ed4fae037","type":"Finding","dc:description":"Igf2 transcript levels in the organs of the 18.5-dpc of wild type mice fetuses were measured using QRT-PCR. Igf2 levels were higher in the extraembryonic organs (placenta, yolk sac, and the amnion), than in the organs of the fetus body (liver, kidney, tongue, brain, heart, lung, muscle, and stomach).\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33567274","rdfs:label":"QRT-PCR","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/96d13319-ec4e-4b18-8800-db2cc7e9cea9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e21ea610-a4d8-4b4f-88f5-09c88440f34e","type":"Finding","dc:description":"IGF2 mutations produce nonfunctional proteins that does not recognize and bind to IGF1-R therefore not causing the activation of cellular pathways required to promote mitogenic activities for growth. The clinical presentation is severe growth delay. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32459985","rdfs:label":"cryo‐electron microscopy (cryo-EM)","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fc5a9230-c1d8-4727-8027-71dd60660854","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e72098e-5075-4649-a7c1-f46904537df0","type":"Finding","dc:description":"Binding of IGF2 to the IR-A causes a structural change, leading  to activation of the tyrosine kinase domain and autophosphorylation. This promotes cell proliferation, survival,  and migration. Mutations in the IGF2 gene can lead to inactivation of this pathway therefore causing severe growth delay.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26217307","rdfs:label":" IGF2 activates IR-A","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/39e89185-94a4-4f94-ae80-63df06bece69_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90f0adb5-a676-4f19-9fea-0626c1220704","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/320a8264-1e6e-4336-8e9b-7fc930d273d2","type":"Finding","dc:description":"Silver-Russel syndrome patients have mutations in the IGF2 gene and present with growth restriction in both prenatal and postnatal phases. This mouse model presents the growth delay seen in all patients.  ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2330056","rdfs:label":"Knockout mouse model ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/85368a7f-b3c7-4b63-b061-d8f5df00e937","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00380648-cd35-4a31-be94-e4f903c09e9a","type":"Finding","dc:description":"Silver-Russel syndrome(SRS) mouse models were significantly smaller than that of their wild type siblings. The fetus and placenta were significantly smaller than the weights of their wild type siblings at 18.5 dpc and 13.5dpc. Additionally, the brain weight, heart, kidney, lung, and tongue were significantly smaller in SRS pups compared to the wild type pups.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33567274","rdfs:label":"Mouse model( +/CHB)","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":7687,"specifiedBy":"GeneValidityCriteria10","strengthScore":16.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/-mJvkiHFZd4","type":"GeneValidityProposition","disease":"obo:MONDO_0014663","gene":"hgnc:5466","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_39e89185-94a4-4f94-ae80-63df06bece69-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}